StonvexLoading…
StonvexStonvexStonvexCore line items from TXG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $150.84M | $642.82M | $476.79M | $327.79M |
Operating Income | $-17.05M | $-60.98M | $-41.44M | $-9.20M |
Net Income | $-13.47M | $-43.54M | $-27.29M | $34.54M |
EPS (Diluted) | $-0.10 | $-0.35 | $-0.22 | $0.00 |
Total Assets | $1.02B | $1.04B | $1.03B | $979.97M |
Total Liabilities | $201.44M | $245.04M | $242.24M | $206.69M |
Cash & Equivalents | $490.29M | $473.97M | $432.71M | $397.71M |
Free Cash Flow OCF − CapEx | $24.52M | $130.12M | $91.11M | $48.59M |
Shares Outstanding | 128.29M | 127.69M | 123.97M | 124.26M |